| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.22 | 6e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.23 | 7e-05 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.17 | 0.0008 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |